Peking University Resources Partners with Trivitron Healthcare to Launch Digital AI Platform

Reuters
Jan 09
Peking University Resources Partners with Trivitron Healthcare to Launch Digital AI Platform

Peking University Resources (Holdings) Co. Ltd., through its health arm ResoHealth based in Dubai, has entered into a partnership with Trivitron Healthcare to launch Trivitron Digital AI. This initiative aims to revolutionize healthcare delivery in Tier-2 and Tier-3 hospitals across India by providing advanced digital infrastructure and interoperable solutions that require minimal additional investment. The collaboration seeks to empower hospitals to deliver high-quality, transparent care and plans to expand its reach to Africa, the Middle East, and Southeast Asia. The project will be led by Dr. G.S.K. Velu, Chairman & Managing Director of Trivitron Healthcare, and Dr. Vas Metupalle.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Peking University Resources (Holdings) Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260109-11986516), on January 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10